Rolf Ljung
121 – 130 of 259
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Venous access - why such diverse experiences of central venous lines?
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.96-96
- Contribution to journal › Published meeting abstract
-
Mark
Management of delivery and neonatal period
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.5-5
- Contribution to journal › Published meeting abstract
-
Mark
Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors
- Contribution to journal › Article
-
Mark
Quality of life in haemophilia carriers - preliminary results of the ESCHQoL study
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.150-150
- Contribution to journal › Published meeting abstract
-
Mark
Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG)
- Contribution to journal › Article
-
Mark
Female haemophilia A caused by skewed X inactivation
- Contribution to journal › Letter
-
Mark
Intracranial haemorrhage in haemophilia A and B.
- Contribution to journal › Scientific review
-
Mark
Why does the mutation G17736A/Val107Val (silent) in the F9 gene cause mild haemophilia B in five Swedish families?
- Contribution to journal › Article
-
Mark
Haemophilia in the first years of life.
- Contribution to journal › Article
-
Mark
Venous Access in Children with Inhibitors
(2008) p.36-41
- Chapter in Book/Report/Conference proceeding › Book chapter
